#pharmaceutical companies

5 stories

#drug pricing #medicaid #cost of living #healthcare affordability #most favored nation policy #news #prescription drug costs #state budgets #trump administration #amgen #attorney general #diabetes

Trump's Medicaid drug deal claims lack detail
The administration projects $64 billion in savings from pharmaceutical deals, but experts say key details remain unclear and the claims overstate the impact.
FactCheck.org · 4m
Pennsylvania sues pharma companies for insulin price collusion
Pennsylvania sues drug makers and PBMs over 1,000% insulin price hikes.
PhillyVoice · 1m
Trump announces all 50 states join Medicaid drug pricing deal
The administration claims billions in savings from a new program linking U.S. drug prices to other wealthy nations, but details remain secret.
ABC News · 1m
Trump's secret drug deals leave savings unclear
The administration claims billions in Medicaid savings, but won't reveal the details of its pharmaceutical agreements.
Fortune · 1m
Amgen vs Merck: which dividend keeps growing?
Two pharma giants both raise dividends yearly, but only one has the portfolio depth to survive the next patent cliff.
24/7 Wall St. · 1m